Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis
VanDevanter, D.R, Heltshe, S.L, Spahr, J, Beckett, V.V, Daines, C.L, Dasenbrook, E.C, Gibson, R.L, Jain, R, Sanders, D.B, Goss, C.H, Flume, P.A
Published in Journal of cystic fibrosis (01.09.2017)
Published in Journal of cystic fibrosis (01.09.2017)
Get full text
Journal Article
KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa
Jain, Raksha, Beckett, V.V., Konstan, M.W., Accurso, F.J., Burns, J.L., Mayer-Hamblett, N., Milla, Carlos, VanDevanter, D.R., Chmiel, J.F.
Published in Journal of cystic fibrosis (01.07.2018)
Published in Journal of cystic fibrosis (01.07.2018)
Get full text
Journal Article